Market Overview - The Hong Kong stock market opened strongly on January 13, with the Hang Seng Index rising by 1.32%, the Hang Seng Tech Index increasing by 1.93%, and the China Enterprises Index up by 1.25% [1] - Notable gains were seen in tech stocks, with Alibaba rising nearly 5% and AI application stocks like Zhiyuan increasing by nearly 6%. The storage chip leader, Zhaoyi Innovation, saw its H-shares surge over 45% on its first trading day [1] Foreign Investment Outlook - According to Wind data, net inflows from southbound funds reached approximately HKD 32.694 billion, marking the highest weekly inflow in over a month and a half [2] - Major foreign institutions, including Goldman Sachs, Morgan Stanley, and UBS, have released positive market outlooks for 2026, driven by expectations of accelerated corporate profit growth, coordinated macro policies, and RMB appreciation [2] - The core drivers for the Chinese stock market's rise are shifting from "valuation recovery" in 2025 to "profit growth" in 2026, as per foreign institutions [2] Sector Recommendations - CITIC Securities suggests that the Hong Kong stock market could experience a second round of valuation recovery and performance revival in 2026, with a focus on sectors such as technology, healthcare, resources, consumer staples, paper, and aviation [2] - Western Securities highlights three factors driving the Hong Kong stock market's rebound: a weaker dollar encouraging international capital allocation to Hong Kong, RMB appreciation attracting Chinese capital back, and a recovery in the Chinese economy supported by inflation and potential debt relief policies [2] Market Sentiment and Trends - Huaxi Securities notes that the Hong Kong market has been underperforming compared to the A-share market, with a need for time to restore investor sentiment. The market has shown signs of recovery since late December, but the consensus for bullish sentiment remains to be solidified [3] - Huatai Securities indicates that the market sentiment index has entered a panic zone, historically leading to a significant increase in the probability of price rises in the following month [3] - ZheShang International maintains a cautious optimism regarding the market's mid-term outlook, despite a weak fundamental backdrop and a slight decline in the funding environment [3] Investment Opportunities - Industrial Securities recommends focusing on leading companies in the AI sector and dividend-paying assets in a low-interest-rate environment, including insurance, banking, energy, property management, and public utilities [4] - ZheShang International is optimistic about sectors benefiting from policy support, such as new energy, innovative pharmaceuticals, and AI technology, as well as low-valuation state-owned enterprises [4] - The 2026 spring performance of the Hong Kong market is expected to be driven by "AI applications, PPI improvement, and expanded domestic demand," with a focus on quality stocks in these areas [4] Company News - Rongchang Biopharmaceutical (09995) signed an exclusive licensing agreement with AbbVie for RC148, receiving an upfront payment of USD 650 million and potential milestone payments up to USD 4.95 billion [9] - WuXi AppTec (02359) forecasts a net profit of CNY 19.151 billion for 2025, representing a year-on-year increase of approximately 103% [9] - Dongfeng Motor Group (00489) reported cumulative vehicle sales of 1.8962 million units for 2025, a slight increase of 0.01% year-on-year [9] - Q Technology (01478) expects camera module sales to reach 45.938 million units for 2025, a year-on-year increase of 43.6% [9]
港股开盘 | 三大指数集体高开 机构：港股整体配置维持哑铃策略
智通财经网·2026-01-13 01:45